Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 6.660 | 7.790 | 1.130 |
Stocks | 1.230 | 1.230 | 0.000 |
Bonds | 91.020 | 91.020 | 0.000 |
Convertible | 1.080 | 1.080 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | - | 23.711 |
Price to Book | 1.521 | 1.807 |
Price to Sales | 1.529 | 2.283 |
Price to Cash Flow | 1.438 | 240.567 |
Dividend Yield | - | 8.086 |
5 Years Earnings Growth | - | 14.102 |
Number of long holdings: 302
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Ashmore EM Inv Grd Corp Dbt Instl III$ C | LU1049820936 | 5.33 | - | - | |
Petroleos de Venezuela SA 8.5% | - | 3.13 | - | - | |
Savannah Energy | GB00BP41S218 | 1.23 | 10.00 | 0.00% | |
Galaxy Pipeline Assets Bidco Ltd. 2.94% | XS2300197030 | 1.12 | - | - | |
C&W Senior Financing Designated Activity Company 6.875% | - | 1.09 | - | - | |
Banco Mercantile del Norte SA Grand Cayman Branch 6.75% | - | 1.00 | - | - | |
First Quantum Minerals Ltd. 8.625% | - | 0.99 | - | - | |
Teva Pharmaceutical Finance Netherlands III B.V. 6.75% | - | 0.96 | - | - | |
Leviathan Bond Ltd Eligible DEDRL 6.75 30-Jun-2030 | IL0011677908 | 0.95 | 91.250 | +0.55% | |
Teva Pharmaceutical Finance Company LLC 6.15% | - | 0.95 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Ashmore EM TR Class Inst GBP Acc | 646.29M | -0.64 | -7.11 | -2.59 | ||
Ashmore EM TR Class Z GBP Inc | 646.29M | -0.64 | -7.20 | - | ||
Ashmore EM TR Class Z2 GBP Inc | 646.29M | -0.56 | -6.98 | - | ||
Ashmore EM TR Fund R GBP | 646.29M | -0.98 | -8.62 | -2.10 | ||
Ashmore EM TR Fund I GBP | 646.29M | 12.60 | -8.21 | -0.89 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review